Related Experiment Video
Updated: Jan 22, 2026

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
Published on: October 6, 2019
The protective effect of interfering TLR9-IRF5 signaling pathway on the development of CVB3-induced myocarditis
Shu Nie1, Boqi Dong2, Shuang Gao3
1Department of Molecular Biology in College of Basic Medical Sciences and Institute of Pediatrics in First Hospital, Jilin University, Changchun 130021, PR China; Department of Pediatric cardiology, The First Hospital of Jilin University, Changchun 130021, PR China.
Abstract:
Since toll-like receptor 9 (TLR9) or interferon regulatory factor 5 (IRF5) was reported to be associated with the development of myocarditis, we wondered if the TLR9-IRF5 pathway could contribute to the development of coxsackievirus B3 (CVB3)-induced myocarditis. We detected signaling molecules of TLR9-IRF5 pathway in CVB3-infected patients and mice. The results showed that TLR9, IRF5 and its downstream molecules such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were significantly increased, and the increase was correlated with the severity of heart injury during CVB3 infection. In addition, we demonstrated that an AAAG ODN with IRF5 interfering activities significantly decreased the levels of the TLR9-IRF5 pathway molecules in hearts, spleens as well as white blood cells, and alleviated the myocarditis in CVB3-infected mice. The data suggest that interfering TLR9-IRF5 pathway could be an approach to treat CVB3-induced myocarditis.
Insights
Interfering with the toll-like receptor 9 (TLR9)-interferon regulatory factor 5 (IRF5) pathway may treat coxsackievirus B3 (CVB3)-induced myocarditis. This pathway
Area of Science:
- Immunology
- Cardiology
- Virology
Background:
- Toll-like receptor 9 (TLR9) and interferon regulatory factor 5 (IRF5) are implicated in myocarditis development.
- Coxsackievirus B3 (CVB3) is a common cause of viral myocarditis.
Purpose of the Study:
- To investigate the role of the TLR9-IRF5 pathway in CVB3-induced myocarditis.
- To explore the therapeutic potential of targeting this pathway.
Main Methods:
- Detection of TLR9-IRF5 pathway molecules in CVB3-infected patients and mice.
- Assessment of an AAAG ODN with IRF5 interfering activity in a mouse model.
Main Results:
- TLR9, IRF5, TNF-α, and IL-6 levels were elevated in CVB3 infection, correlating with heart injury severity.
- AAAG ODN treatment reduced pathway molecule levels and alleviated myocarditis in mice.
Conclusions:
- The TLR9-IRF5 pathway contributes to CVB3-induced myocarditis.
- Interfering with the TLR9-IRF5 pathway shows promise for treating CVB3 myocarditis.
More Related Videos
11:48Grafting of Beads into Developing Chicken Embryo Limbs to Identify Signal Transduction Pathways Affecting Gene Expression
Published on: January 17, 2016
06:46Mouse Fetal Whole Intestine Culture System for Ex Vivo Manipulation of Signaling Pathways and Three-dimensional Live Imaging of Villus Development
Published on: September 4, 2014
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Insulin: The Receptor and Signaling Pathways
IP3/DAG Signaling Pathway